Dow Jones now could struggle as COVID numbers climb. Australia has announced a total lockdown that could last at least six weeks.
Investors are also waiting for the latest update on Americans seeking unemployment benefits.
Economists anticipate that another 1.423 million workers will have filed for unemployment for the week ending August 1.
This report is a critical preview of the trends in the U.S. jobs market.
Tomorrow, the U.S. Labor Department will release the official jobs report for July.
I'll come right out and say it: Every investor should be doing their level best to position themselves at the epicenter of biotechnology – pharmaceuticals – right now.
These stocks are leading a soaring stock market, particularly the NASDAQ Composite, which is at all-time highs. Of the index's 10 biggest gainers at midday yesterday, half were biotechs.
Obviously, the race to find a vaccine or even a proven therapy for the novel coronavirus pandemic is a huge driver of the profits here. My paid subscribers recently got the chance to book 375% gains on half of one of our vaccine research plays, and took 70% in profits on another.
But there's much more going on.
The sheer amount and volume of capital pouring into this sector like a firehose – it's nothing short of breathtaking.
I'm going to show you my favorite, low-risk way to tap that immense growth.
But first, you have to see some of these numbers… Full Story
But first, you have to see some of these numbers...
Biotech stocks find themselves in a very interesting, and potentially very profitable, situation right now.
It's widely believed by public health officials that we can't return to "normal" until scientists discover a coronavirus vaccine that can be widely distributed.
That's the primary reason why the Trump administration launched "Operation Warp Speed."
The U.S. government is investing billions of dollars in biotech companies to develop a COVID-19 vaccine as quickly as possible – so the world can return to normal.
But not all biotech stocks are worth buying right now.
by Mike Stenger
A Qualtrics IPO has been one of the more talked-about offerings coming on the horizon lately.
Once the Qualtrics stock symbol surfaces, there could be a rush on the stock.
But should you invest in Qualtrics?
This tech stock is checking all of Chris Johnson's boxes when it comes to the best stock to trade this earnings season…
As companies everywhere settle into a post-COVID virtual reality, this company could be a leading provider of tech solutions.
They just crushed earnings expectations for the fourth quarter in a row, and according to Chris, the profit potential won't stop there.
See the full details in this, the latest from Fast Profits with Money Morning...
by David Zeiler
With an Apple stock split just around the corner, many investors will want to brush up on how these events work and how they will be affected.
Stock splits have become increasingly rare, so people are less familiar with what to expect.
That's why we've put together a comprehensive Q&A for you.
We have answers to all of your questions...
Despite poor earnings performance, investors reacted positively to BP's recent announcement of a new green initiative, causing BP shares to rise nearly 8%.
But our Andrew Keene isn't seeing eye-to-eye with those rushing to purchase some shares of BP right now.
So here's what to buy instead if you want to profit...
Special purpose acquisition companies, or SPACs, have been all the rage with investors this year.
These special companies give investors a new way to invest in IPOs and some of the hottest companies on the planet.
Even better, investors have the chance to reclaim their investment if they don't like the deal their SPAC makes.
As usual, there's more to the story than that, and we're here to help.
To help you understand what these investment vehicles are and whether they're worthy of your money we're taking a deep dive into them today.
We'll show you exactly how these investments work and we'll show you the best SPAC stocks to buy now too.
by Mike Stenger
The cloud computing industry was worth $266 billion in 2019.
Markets and Markets projects It will be $832 billion by 2025.
212% is a lot of growth five years.
Today, we're going to show you the best cloud stocks to buy as this industry erupts.
The Dow Jones now is ticking up despite private payrolls for July coming in worse than expected.
According to ADP, private jobs were 167,000 for the month, well below the consensus forecast of 1 million.
The news is sobering ahead of Friday's official jobs report from the U.S. Labor Department.
More below on what's moving the Dow today.
